Did You Know?
What We Fund
Among adults, less than 5% of those with cancer are enrolled in clinical trials. Yet for children, more than 60% of those with cancer participate in some form of clinical trial. CureSearch supports clinical trials that show promise in making a difference for children with cancer, today.
New CureSearch Young Investigator Kara Davis, DO, performs research at Stanford University on protein expression in B-cell precursor acute lymphoblastic leukemia. Dr. Davis’s work examines the phenotypes of B-cells, focusing on the difference between normal, healthy B-cells and those involved in the development of BCP ALL.read more